Metraipolis › archive › dc_3aa8ebc218fb

Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review — Europe PMC PMID:40963567

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40963567
DOI
10.3389/fmed.2025.1658583
License (as archived)
solo-consultazione
Archived
2026-11-10T04:46:46.194Z
SHA-256 of the archived text
916e91e48034762498fc365d006eba74ef1d7b3c089a01c9278102c2a2c249b8
Stable URL of this page
https://metraipolis.com/documento/dc_3aa8ebc218fb

How to cite

Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review — Europe PMC PMID:40963567 — Europe PMC (en), https://europepmc.org/article/MED/40963567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3aa8ebc218fb (Metraipolis archive dc_3aa8ebc218fb, sha256 916e91e48034762498fc365d006eba74ef1d7b3c089a01c9278102c2a2c249b8)
BibTeX
@misc{dc3aa8ebc218fb,
  title = {Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review — Europe PMC PMID:40963567},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40963567},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3aa8ebc218fb; sha256 916e91e48034762498fc365d006eba74ef1d7b3c089a01c9278102c2a2c249b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963567. Agents can read the archived copy with the MCP tool read_document.